Pre-Operative Guided Meditation to Reduce Pre-Operative Anxiety in Patients Undergoing Cancer-Directed Surgery
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT06949943
- Status
- Recruiting
Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Behavioral Intervention — BEHAVIORALListen to guided meditation
- Behavioral Intervention — BEHAVIORALWear noise cancelling headphones
- Electronic Health Record Review — OTHERAncillary studies
- Survey Administration — OTHERAncillary studies
Study Details
This clinical trial tests how well guided meditation, compared to silence, works to reduce pre-operative anxiety in patients undergoing cancer-directed surgery. Pre-operative anxiety affects patient experience and has been found to be a predictor of severe post-operative pain and chronic pain after surgery, influencing the success and quality of a patient's recovery. While medication is often prescribed to improve anxiety symptoms, research has showed that mindfulness techniques can be used to decrease anxiety, improve comfort, and can impact both psychological and physiologic symptoms. Completing pre-operative guided meditation may work well to reduce pre-operative anxiety in patients undergoing cancer directive surgery.
Key Dates
- Start date
- Mar 14, 2025
- Status verified
- May 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm I (guided meditation)Patients listen to 10 minutes of guided meditation prior to surgery.
- Active Comparator: Arm II (noise cancelling headphones)Patients wear noise cancelling headphones for 10 minutes prior to surgery.
Primary Outcome Measure
Pre-operative anxiety (PROMIS Anxiety scale) [ Time Frame: Pre and post intervention, approximately 10 minutes ]
Central Contacts
- The Ohio State University Comprehensive Cancer Center800-293-5066
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | Maryanna Klatt, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Columbus, OH
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid TumorsRecruiting · SWOG Cancer Research Network · Anchorage, Alaska
- Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)Recruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio